ATE449861T1 - Verfahren zur fermentativen herstellung von heterologen genprodukten in milchsäurebakterien - Google Patents

Verfahren zur fermentativen herstellung von heterologen genprodukten in milchsäurebakterien

Info

Publication number
ATE449861T1
ATE449861T1 AT01978228T AT01978228T ATE449861T1 AT E449861 T1 ATE449861 T1 AT E449861T1 AT 01978228 T AT01978228 T AT 01978228T AT 01978228 T AT01978228 T AT 01978228T AT E449861 T1 ATE449861 T1 AT E449861T1
Authority
AT
Austria
Prior art keywords
lactic acid
acid bacteria
heterologue
gene products
fermentative production
Prior art date
Application number
AT01978228T
Other languages
English (en)
Inventor
Astrid Vrang
Soeren Madsen
Lars Bredmose
Peter Ravn
Jose Arnau
Mads Johnsen
Anne Steenberg
Hans Israelsen
Original Assignee
Bioneer As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioneer As filed Critical Bioneer As
Application granted granted Critical
Publication of ATE449861T1 publication Critical patent/ATE449861T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
AT01978228T 2000-10-20 2001-10-19 Verfahren zur fermentativen herstellung von heterologen genprodukten in milchsäurebakterien ATE449861T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69220500A 2000-10-20 2000-10-20
PCT/DK2001/000693 WO2002033109A2 (en) 2000-10-20 2001-10-19 Fermentation method for production of heterologous gene products in lactic acid bacteria

Publications (1)

Publication Number Publication Date
ATE449861T1 true ATE449861T1 (de) 2009-12-15

Family

ID=24779648

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01978228T ATE449861T1 (de) 2000-10-20 2001-10-19 Verfahren zur fermentativen herstellung von heterologen genprodukten in milchsäurebakterien

Country Status (12)

Country Link
US (1) US7358067B2 (de)
EP (1) EP1356073B1 (de)
JP (1) JP4399158B2 (de)
AT (1) ATE449861T1 (de)
AU (2) AU2002210401B2 (de)
CA (1) CA2426084C (de)
DE (1) DE60140626D1 (de)
DK (1) DK1356073T3 (de)
ES (1) ES2336647T3 (de)
NZ (1) NZ525394A (de)
PT (1) PT1356073E (de)
WO (1) WO2002033109A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9521568D0 (en) * 1995-10-20 1995-12-20 Lynxvale Ltd Delivery of biologically active polypeptides
EP1239032A1 (de) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Milchsäurebakterien als Mitteln zur Behandlung und Vorbeugung von Allergie
US7780961B2 (en) * 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
EP1560935A2 (de) * 2002-11-15 2005-08-10 VIB vzw Selbst-enthaldender lactobacillus strain
EP1708741B1 (de) * 2003-12-24 2016-03-30 Aduro Biotech Fusionsproteine kodierende rekombinante nucleinsäure-moleküle mit antigenen und bakteriellen sekretorischen signal-polypeptiden, expressionskassetten und bakterien und anwendungsverfahren dafür
US7842289B2 (en) 2003-12-24 2010-11-30 Aduro Biotech Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
US20070048823A1 (en) * 2005-08-26 2007-03-01 Cerenis Therapeutics, S.A. Compositions and Methods for Producing Apolipoprotein Gene Products in Lactic Acid Bacteria
GB0522303D0 (en) * 2005-11-01 2005-12-07 Chiron Srl Culture method
DK2119450T3 (da) 2005-11-29 2013-05-06 Actogenix Nv Induktion af mucosal tolerance over for pankreatisk ø-beta-celle-autoantigener
UA95795C2 (ru) * 2006-01-27 2011-09-12 Юниверсити Оф Массачусетс Способ изготовления продукта из биомассы и установка по производству топлива из биомассы
US7935804B2 (en) 2006-03-01 2011-05-03 Aduro Biotech Engineered Listeria and methods of use thereof
RU2495129C2 (ru) * 2007-01-12 2013-10-10 Актогеникс Н.В. ПРОМОТОРЫ Lactococcus И ИХ ПРИМЕНЕНИЕ:
CA3037889C (en) 2007-01-25 2022-09-13 Intrexon Actobiotics Nv Treatment of immune disease by mucosal delivery of antigens
JP5576115B2 (ja) * 2007-04-26 2014-08-20 中外製薬株式会社 高濃度アミノ酸含有培地を用いた細胞の培養方法
AU2009219150A1 (en) * 2008-02-27 2009-09-03 Qteros, Inc. Methods for the conversion of plant materials into fuels and chemicals by sequential action of two microorganisms
US20090286294A1 (en) * 2008-04-04 2009-11-19 University Of Massachusetts Methods and Compositions for Improving the Production of Fuels in Microorganisms
US20100105114A1 (en) * 2008-06-11 2010-04-29 University Of Massachusetts Methods and Compositions for Regulating Sporulation
CA2735909C (en) * 2008-09-08 2019-05-21 Jurag Separation A/S Process for controlling the ph and level of target ions of a liquid composition
US20100086981A1 (en) * 2009-06-29 2010-04-08 Qteros, Inc. Compositions and methods for improved saccharification of biomass
BRPI1013829A2 (pt) * 2009-04-20 2019-09-24 Qteros Inc composições e métodos para fermentação de biomassa
EP2275527A1 (de) 2009-07-17 2011-01-19 ActoGeniX NV Kulturmedium zur Fermentation von Bakterien welches frei von tierischen Bestandteilen ist
PL3202785T3 (pl) 2009-10-26 2024-08-12 F. Hoffmann-La Roche Ag Sposób wytwarzania glikozylowanej immunoglobuliny
WO2011081658A2 (en) * 2009-12-15 2011-07-07 Qteros, Inc. Methods and compositions for producing chemical products from c. phytofermentants
GB2478791A (en) * 2010-03-19 2011-09-21 Qteros Inc Ethanol production by genetically-modified bacteria
PL2625262T3 (pl) 2010-10-05 2016-05-31 Novo Nordisk Healthcare Ag Sposób wytwarzania białka
JP5979684B2 (ja) * 2011-12-15 2016-08-24 セラム インスティチュート オブ インディア プライベイト リミテッド 莢膜多糖の収量向上のための細菌培養方法
NZ627372A (en) 2012-01-12 2016-04-29 Auxilium Int Holdings Inc Clostridium histolyticum enzymes and methods for the use thereof
BR112015032960B1 (pt) 2013-07-04 2021-01-05 F. Hoffmann-La Roche Ag imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro
CN104988107B (zh) * 2015-05-19 2018-06-08 中国农业科学院兰州兽医研究所 一种高效表达口蹄疫病毒抗原基因的重组乳酸杆菌及其制备方法和应用
KR101915950B1 (ko) * 2018-01-09 2018-11-07 주식회사 쎌바이오텍 시스타틴을 발현 및 분비하는 위장관 질환 치료 약물 전달용 미생물 및 그를 포함하는 위장관 질환 예방 또는 치료용 약제학적 조성물
KR101915951B1 (ko) * 2018-01-09 2018-11-07 주식회사 쎌바이오텍 P8 단백질을 발현 및 분비하는 위장관 질환 치료 약물 전달용 미생물 및 그를 포함하는 위장관 질환 예방 또는 치료용 약제학적 조성물
KR102281858B1 (ko) * 2019-09-11 2021-07-26 주식회사 쎌바이오텍 유산균 유래 p8 단백질의 발현 컨스트럭트를 포함하는 대장 질환의 치료 또는 예방용 조성물
CN111254103B (zh) * 2019-11-19 2023-06-02 河南省生物工程技术研究中心 一种非洲猪瘟基因工程疫苗高密度发酵补料培养基及发酵工艺
CN112795527A (zh) * 2021-03-05 2021-05-14 昆明理工大学 二氢蝶呤醛缩酶基因的用途
CN112813085B (zh) * 2021-03-05 2023-03-31 昆明理工大学 焦磷酸酶基因的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ286635A (en) * 1992-12-30 1997-06-24 Chr Hansen As Recombinant lactic acid bacterium, dna containing a lactic acid promoter
ATE226637T1 (de) * 1996-09-06 2002-11-15 Bioteknologisk Inst Milchsäurebakterielles regulierbares expressionssystem
ES2276691T3 (es) 1999-08-06 2007-07-01 Bioneer A/S Peptidos señales aislados de lactococcus lactis.

Also Published As

Publication number Publication date
AU2002210401B2 (en) 2006-07-20
EP1356073A2 (de) 2003-10-29
PT1356073E (pt) 2010-02-15
DK1356073T3 (da) 2010-04-06
AU1040102A (en) 2002-04-29
DE60140626D1 (de) 2010-01-07
EP1356073B1 (de) 2009-11-25
WO2002033109A2 (en) 2002-04-25
CA2426084A1 (en) 2002-04-25
JP2004511248A (ja) 2004-04-15
CA2426084C (en) 2013-12-10
US7358067B2 (en) 2008-04-15
NZ525394A (en) 2005-12-23
US20020137140A1 (en) 2002-09-26
WO2002033109A3 (en) 2003-09-04
JP4399158B2 (ja) 2010-01-13
ES2336647T3 (es) 2010-04-15

Similar Documents

Publication Publication Date Title
ATE449861T1 (de) Verfahren zur fermentativen herstellung von heterologen genprodukten in milchsäurebakterien
CN101253196B (zh) 通过胰蛋白酶变体切割胰岛素前体
EP0387319B1 (de) Sekretorische leader-sequenzen
ATE318917T1 (de) Verfahren zur bakteriellen herstellung von heterologen polypeptiden mit disulfidbrücke
Roberts et al. Heterologous gene expression in Aspergillus niger: a glucoamylase-porcine pancreatic prophospholipase A2 fusion protein is secreted and processed to yield mature enzyme
CN107532190A (zh) 用于肽生产的融合伴侣
ATE493503T1 (de) Verfahren zur fermentativen herstellung von proteinen
NZ510385A (en) E. coli enterotoxin II signal peptide and a microorganism expressing a fusion protein of the MST peptide and a heterologous protein, such as human growth hormone
NO911138L (no) Bakterielle vektorer.
WO2013163654A3 (en) Nucleic acids, cells, and methods for producing secreted proteins
US5268270A (en) Process for producing proteins using gram negative host cells
KR970065558A (ko) 분비형 Kex2 유도체의 제조방법
DE59410401D1 (de) VERFAHREN ZUR HERSTELLUNG REKOMBINANTER PilC-PROTEINE
JPH07170984A (ja) 新規アミノ酸配列及び該アミノ酸配列をコード するdnaを保有する発現ベクターを 組み込んだバチルス・ブレビスを用いる 有用物質の製造法
EP1307569B1 (de) Herstellung eines rekombinanten proteins in prokaryotischen wirtszellen durch kodonsoptimisierung
CN105051060A (zh) 用于增强蛋白质表达的融合肽
ATE480624T1 (de) Yapsin-mangelmutantenstamm von hansenula polymorpha sowie verfahren zur herstellung rekombinanter proteine damit
NO971110L (no) Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin
DE3483566D1 (de) Fermentationsverfahren und erhaltene produkte.
Honjo et al. Secretion of human growth hormone in Bacillus subtilis using prepropeptide coding region of Bacillus amyloliquefaciens neutral protease gene
Schnappinger et al. Extracellular expression of native human anti-lysozyme fragments in Staphylococcus carnosus
EP0952158A4 (de) Modifizierte methylotrophe p. pastoris hefe, welche menschliches wachstumshormon sekretiert
Hellebust et al. Effect of protein fusion on the stability of proteolytically sensitive sites in recombinant DNA proteins
EP2275556A1 (de) Schnell-Screeningverfahren für Translationsfusionspartner zur Herstellung rekombinanter Proteine und daraus gescreente Translationsfusionspartner
US6821755B2 (en) Preparation of a recombinant protein in a prokaryotic host cell

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1356073

Country of ref document: EP